{"id":43020,"date":"2024-11-14T15:06:33","date_gmt":"2024-11-14T15:06:33","guid":{"rendered":"https:\/\/www.theisn.org\/?page_id=43020"},"modified":"2026-10-21T19:04:24","modified_gmt":"2026-10-21T19:04:24","slug":"ckm-roadmap","status":"publish","type":"page","link":"https:\/\/www.theisn.org\/initiatives\/toolkits\/ckm-roadmap\/","title":{"rendered":"Cardio-Kidney-Metabolic Initiative"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]<\/p>\n

\n
\n

Kidney diseases are intricately linked to increased morbidity with, and mortality from, other diseases and infections. An integrated approach to noncommunicable disease (NCD) prevention and management that recognizes the burden of kidney disease and concomitant co-morbidities is critical to ensure no disease is left behind.<\/p>\n

Since 2022, the ISN has led a cardio-kidney-metabolic initiative, bringing together nephrologists and cardiologists to identify existing gaps related to targets for therapy, optimal management, and barriers to implementation. The aim is to fill these gaps by developing toolkits to support clinicians and advance care for individuals living with cardio-kidney-metabolic conditions and complications.<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_column_text]<\/p>\n

\n
\n

Roadmap to Persons Living with Cardio-Kidney-Metabolic Conditions<\/strong><\/p>\n

To guide our work, we have developed an interactive roadmap<\/a>, which provides clinicians with an overview of the management of individuals living with cardio-kidney-metabolic conditions and complications. Visit the roadmap here.<\/a><\/strong><\/p>\n<\/div>\n

\"\"<\/a><\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=”16px”][vc_text_separator title=”Resources” title_align=”separator_align_left” border_width=”3″][vc_empty_space height=”16px”][vc_tta_accordion spacing=”5″ gap=”5″ c_position=”right” active_section=”” collapsible_all=”true” el_class=”accordion-isn”][vc_tta_section title=”Meeting Report – ISN Cardiovascular-Kidney-Metabolic Health Expert Forum” tab_id=”Forum”][vc_column_text]<\/p>\n

Access the full paper here<\/a>.<\/strong>\"\"\"\"<\/a><\/h3>\n
Download the infographic here<\/a>.<\/h5>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”Optimisation of RAASi Therapy Toolkit” tab_id=”RAASi”][vc_column_text]<\/p>\n

The optimization of RAASi therapy and management of related complications was selected as the first implementation activity of the roadmap given the significant unmet need in this area, and the underutilization of RAASi therapy. The toolkit aims to provide\u00a0focused, up-to-date, practical tools, and serve\u00a0as a hands-on reference for nephrologists and cardiologists, as well as other healthcare professionals,\u00a0involved in the multidisciplinary care of patients with cardio-renal complications.<\/p>\n

Five\u00a0educational and clinical tools were developed on the following topics:\u00a0nuts-and-bolts of RAASi therapy; management of hyperkalemia; diet; managing acute declines in eGFR; and, patient knowledge.<\/p>\n

NEW: A brand new tool on indications for MRAs in the management of cardio-kidney risk has just been added. Access it here<\/a>.<\/p>\n

Access the entire optimization of RAASi therapy toolkit here.<\/a><\/p>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”Optimization of SGLT2i Therapy Toolkit” tab_id=”SGLT2i”][vc_column_text]The toolkit on the optimization of SGLT2i therapy was the next output selected for the cardio-kidney-metabolic initiative.<\/p>\n

The toolkit contains focused and practical infographics on:<\/p>\n